Proteus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 4.00 M
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 153.80 Cr
About Proteus Pharmaceuticals
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2004PTC145936
-
Company No.
145936
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Apr 2004
-
Date of AGM
30 Sep 2008
-
Date of Balance Sheet
31 Mar 2008
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Proteus Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alpesh Mehta
|
Director | 10-Oct-2005 | Current |
|
Ramesh Mehta
|
Director | 03-Jan-2006 | Current |
Financial Performance of Proteus Pharmaceuticals.
Enhance accessibility to Proteus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proteus Pharmaceuticals?
Unlock access to Proteus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹153.80 Cr
₹0
Charges Breakdown by Lending Institutions
- Edelweiss Asset Reconstruction Company Limited : 96.50 Cr
- The Lakshmivilas Bank Limited : 30.00 Cr
- Canara Bank : 17.30 Cr
- Global Trade Finance Limited : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2010 | Edelweiss Asset Reconstruction Company Limited | ₹48.25 Cr | Open |
| 18 Jun 2009 | Global Trade Finance Limited | ₹10.00 Cr | Open |
| 17 Mar 2009 | The Lakshmivilas Bank Limited | ₹25.00 Cr | Open |
| 23 Dec 2008 | The Lakshmivilas Bank Limited | ₹5.00 Cr | Open |
| 18 Oct 2008 | Edelweiss Asset Reconstruction Company Limited | ₹48.25 Cr | Open |
How Many Employees Work at Proteus Pharmaceuticals?
Unlock and access historical data on people associated with Proteus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proteus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proteus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.